aster.cloud aster.cloud
  • /
  • Platforms
    • Public Cloud
    • On-Premise
    • Hybrid Cloud
    • Data
  • Architecture
    • Design
    • Solutions
    • Enterprise
  • Engineering
    • Automation
    • Software Engineering
    • Project Management
    • DevOps
  • Programming
    • Learning
  • Tools
  • About
  • /
  • Platforms
    • Public Cloud
    • On-Premise
    • Hybrid Cloud
    • Data
  • Architecture
    • Design
    • Solutions
    • Enterprise
  • Engineering
    • Automation
    • Software Engineering
    • Project Management
    • DevOps
  • Programming
    • Learning
  • Tools
  • About
aster.cloud aster.cloud
  • /
  • Platforms
    • Public Cloud
    • On-Premise
    • Hybrid Cloud
    • Data
  • Architecture
    • Design
    • Solutions
    • Enterprise
  • Engineering
    • Automation
    • Software Engineering
    • Project Management
    • DevOps
  • Programming
    • Learning
  • Tools
  • About
  • Tech

Pandemic-Driven Changes In Pharma Here To Stay As New Clinical Trial Models Take Hold

  • aster.cloud
  • October 26, 2021
  • 3 minute read
Informa report

COVID-19 physical distancing requirements forced change in how traditional clinical trials were conducted and a new Informa Pharma and Oracle study shows the industry is not looking back. Of the 251 people surveyed, 84% implemented alternative tactics to continue their existing clinical trials and/or start new trials during the pandemic. Of those respondents, 82% said these approaches had positively impacted their clinical trials overall. Looking to the future, 97% indicated their organization would continue using at least one of these new methods moving forward, leading with remote monitoring and video (eHealth) visits.

“At the onset of the pandemic, the industry had to quickly adapt to keep trials afloat and this forced change helped researchers understand when and how to implement these approaches to improve clinical research,” said Henry McNamara, senior vice president and general manager, Oracle Health Sciences. “Methods and technology that were being explored pre-pandemic have come front and center during the past 18 months. As clinical trials continue to evolve, study teams can rest assured that technology will help carry them into the future and speed new discoveries.”


Partner with aster.cloud
for your next big idea.
Let us know here.



From our partners:

CITI.IO :: Business. Institutions. Society. Global Political Economy.
CYBERPOGO.COM :: For the Arts, Sciences, and Technology.
DADAHACKS.COM :: Parenting For The Rest Of Us.
ZEDISTA.COM :: Entertainment. Sports. Culture. Escape.
TAKUMAKU.COM :: For The Hearth And Home.
ASTER.CLOUD :: From The Cloud And Beyond.
LIWAIWAI.COM :: Intelligence, Inside and Outside.
GLOBALCLOUDPLATFORMS.COM :: For The World's Computing Needs.
FIREGULAMAN.COM :: For The Fire In The Belly Of The Coder.
ASTERCASTER.COM :: Supra Astra. Beyond The Stars.
BARTDAY.COM :: Prosperity For Everyone.

The survey, Clinical Trial Management in a Post-Pandemic World, polled participants from biopharmaceutical and medical device companies, as well as CROs involved in the operations and management of clinical trials from July to September 2021. Respondents, who were largely from North America and Europe, with others from APAC and other regions, were asked about changes made to their clinical trials during the pandemic, the effect of these adaptations, and the impact of these changes on the future of clinical trials.

Read More  HSBC And Microsoft Join Forces To Support The New Feeding America Workforce Development Initiative

 

Newly implemented trial methods bring benefits to trials and patients

Of the various methods noted, 45% of respondents said they had adopted remote monitoring in their trials during the pandemic, nearly doubling the number of respondents who reported using remote monitoring a year ago. Among the newly adopted methods that companies plan to continue to use post-pandemic, remote monitoring (32%), video visits (28%), electronic health records (EHR) (24%), and phone visits led the pack (24%).

The most common positive impacts of the alternative approaches adopted during the pandemic included more timely data access (48%), improved flexibility for patients (41%), and increased speed (38%).

When asked about their confidence in the data generated by newly adopted approaches, 92% of respondents stated they were equally or more confident in the data collected from these methods, compared to data collected via pre-pandemic methods. This was a marked change from the 2020 survey when nearly half of respondents said that data reliability and quality (50%) and data collection (45%) were key concerns in adopting decentralized clinical trials. This significant increase in confidence supports the industry’s continued progress towards more decentralized models.

The study also found that improving the patient experience is a priority. Many respondents (61%) believe allowing patients’ choice will have a positive impact on clinical research and well over half (58%) said that their organizations plan to give patients the option to choose how they participate in clinical trials moving forward.

As the shift to decentralized trials continues, survey respondents expect their organizations to continue using hybrid (44%) and fit-for-purpose (42%) models after the pandemic. Of the four models considered—site-based, fit-for-purpose, hybrid, and decentralized—respondents expect the use of the site-based model to decrease the most (24%).

Read More  Real-Time Data Integration From Oracle To Google BigQuery Using Striim

“The COVID-19 pandemic challenged status quo and served as a catalyst for the adoption of the technology-enabled ‘patient-centric’ decentralized clinical trials model,” said Dr. Nimita Limaye, research vice president, IDC. “As data overflowed from diverse sources, data collection models transitioned from ‘discrete’ data points to ‘continuous’ measures and from ‘local optimums’ to unified cloud-native platforms. The reality of this shift to the new norm has led to most of the industry planning on continuing to implement newer decentralized clinical trial models, with a significant reduction in the traditional site-based model. It is evident that patient optionality rules the day, with most organizations planning on giving patients the choice about how they participate in clinical trials.”

To learn more about the study, join an in-depth webinar on the research and findings on October 26th here or download the full report here. Learn more about Oracle Health Sciences Clinical One here.

About Oracle Health Sciences

As a leader in Life Sciences cloud technology, Oracle Health Sciences’ Clinical One and Safety One are trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance. With over 20 years’ experience, Oracle Health Sciences is committed to supporting clinical development, delivering innovation to accelerate advancements, and empowering the Life Sciences industry to improve patient outcomes. Oracle Health Sciences. For life.

About Oracle

Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

Trademarks

Oracle, Java, and MySQL are registered trademarks of Oracle Corporation.


For enquiries, product placements, sponsorships, and collaborations, connect with us at [email protected]. We'd love to hear from you!

Our humans need coffee too! Your support is highly appreciated, thank you!

aster.cloud

Related Topics
  • COVID-19
  • Oracle
  • Oracle Health Sciences
You May Also Like
Getting things done makes her feel amazing
View Post
  • Computing
  • Data
  • Featured
  • Learning
  • Tech
  • Technology

Nurturing Minds in the Digital Revolution

  • April 25, 2025
View Post
  • Tech

Deep dive into AI with Google Cloud’s global generative AI roadshow

  • February 18, 2025
Volvo Group: Confidently ahead at CES
View Post
  • Tech

Volvo Group: Confidently ahead at CES

  • January 8, 2025
zedreviews-ces-2025-social-meta
View Post
  • Featured
  • Gears
  • Tech
  • Technology

What Not to Miss at CES 2025

  • January 6, 2025
View Post
  • Tech

IBM and Pasqal Plan to Expand Quantum-Centric Supercomputing Initiative

  • November 21, 2024
Black Friday Gifts
View Post
  • Tech

Black Friday. How to Choose the Best Gifts for Yourself and Others, Plus Our Top Recommendations.

  • November 16, 2024
zedreviews-Apple-iPhone-16-Pro-finish-lineup-240909
View Post
  • Featured
  • Gears
  • Tech
  • Technology
  • Tools

Apple debuts iPhone 16 Pro and iPhone 16 Pro Max

  • September 10, 2024
zedreviews-Apple-iPhone-16-Apple-Intelligence-240909
View Post
  • Featured
  • Gears
  • Tech
  • Technology

Apple introduces iPhone 16 and iPhone 16 Plus

  • September 10, 2024

Stay Connected!
LATEST
  • 1
    Just make it scale: An Aurora DSQL story
    • May 29, 2025
  • 2
    Reliance on US tech providers is making IT leaders skittish
    • May 28, 2025
  • Examine the 4 types of edge computing, with examples
    • May 28, 2025
  • AI and private cloud: 2 lessons from Dell Tech World 2025
    • May 28, 2025
  • 5
    TD Synnex named as UK distributor for Cohesity
    • May 28, 2025
  • Weigh these 6 enterprise advantages of storage as a service
    • May 28, 2025
  • 7
    Broadcom’s ‘harsh’ VMware contracts are costing customers up to 1,500% more
    • May 28, 2025
  • 8
    Pulsant targets partner diversity with new IaaS solution
    • May 23, 2025
  • 9
    Growing AI workloads are causing hybrid cloud headaches
    • May 23, 2025
  • Gemma 3n 10
    Announcing Gemma 3n preview: powerful, efficient, mobile-first AI
    • May 22, 2025
about
Hello World!

We are aster.cloud. We’re created by programmers for programmers.

Our site aims to provide guides, programming tips, reviews, and interesting materials for tech people and those who want to learn in general.

We would like to hear from you.

If you have any feedback, enquiries, or sponsorship request, kindly reach out to us at:

[email protected]
Most Popular
  • 1
    Cloud adoption isn’t all it’s cut out to be as enterprises report growing dissatisfaction
    • May 15, 2025
  • 2
    Hybrid cloud is complicated – Red Hat’s new AI assistant wants to solve that
    • May 20, 2025
  • 3
    Google is getting serious on cloud sovereignty
    • May 22, 2025
  • oracle-ibm 4
    Google Cloud and Philips Collaborate to Drive Consumer Marketing Innovation and Transform Digital Asset Management with AI
    • May 20, 2025
  • notta-ai-header 5
    Notta vs Fireflies: Which AI Transcription Tool Deserves Your Attention in 2025?
    • May 16, 2025
  • /
  • Technology
  • Tools
  • About
  • Contact Us

Input your search keywords and press Enter.